Vector Surgical

Executive Summary

Vector Surgical is a private US medical device company addressing a critical need in cancer surgery: accurate tissue orientation and margin marking. Its proprietary MarginMarker sterile ink kits and CorrectClips radiographic markers enable precise intraoperative marking of surgical margins, reducing pathology interpretation errors and re-excision rates. Serving surgeons, pathologists, and radiologists across multiple cancer specialties, the company has built a niche in the surgical oncology market since its founding in 2005. While growth has been steady, Vector Surgical lacks disclosed funding or revenue milestones, suggesting a conservative trajectory. With rising cancer incidence and a focus on precision medicine, the company is well-positioned to expand its footprint, though competition from larger players remains a challenge.

Upcoming Catalysts (preview)

• TBDFDA clearance for next-generation MarginMarker product line70% success
• TBDStrategic partnership or distribution agreement with a major medical device company50% success
• TBDPublication of clinical study demonstrating reduced re-excision rates with CorrectClips60% success